Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Andreeff

Showing results (501-510 of 506) with videos related to

Pageof 51
Sort By:
You have reached the last page of results.This site can display upto 506 results.
The Lancet. Haematology|September 8, 2020
10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trialCourtney D DiNardo, Abhishek Maiti, Caitlin R Rausch, et al.
Signal Transduction and Targeted Therapy|April 2, 2022
Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemiaQi Zhang, Bridget Riley-Gillis, Lina Han, et al.
Leukemia|August 23, 2024
Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international communityBranko Cuglievan, Hagop Kantarjian, Jeffrey E Rubnitz, et al.
Nature Communications|May 19, 2022
Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemiaNatalia Baran, Alessia Lodi, Yogesh Dhungana, et al.
Cancer Cell|April 13, 2016
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in MiceElizabeth C Townsend, Mark A Murakami, Alexandra Christodoulou, et al.
Cancer Cell|August 2, 2016
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in MiceElizabeth C Townsend, Mark A Murakami, Alexandra Christodoulou, et al.
Pageof 51

Showing results (501-510 of 506) with videos related to

Sort By:
Pageof 51
You have reached the last page of results.This site can display upto 506 results.
The Lancet. Haematology|September 8, 2020
10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trialCourtney D DiNardo, Abhishek Maiti, Caitlin R Rausch, et al.
Signal Transduction and Targeted Therapy|April 2, 2022
Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemiaQi Zhang, Bridget Riley-Gillis, Lina Han, et al.
Leukemia|August 23, 2024
Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international communityBranko Cuglievan, Hagop Kantarjian, Jeffrey E Rubnitz, et al.
Nature Communications|May 19, 2022
Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemiaNatalia Baran, Alessia Lodi, Yogesh Dhungana, et al.
Cancer Cell|April 13, 2016
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in MiceElizabeth C Townsend, Mark A Murakami, Alexandra Christodoulou, et al.
Cancer Cell|August 2, 2016
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in MiceElizabeth C Townsend, Mark A Murakami, Alexandra Christodoulou, et al.
Pageof 51